TISSIUM Selected for the French Tech 120 Program

For the fifth year in a row PARIS, FRANCE / ACCESSWIRE / May 22, 2024 / TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, confirms its selection

Related Keywords

United States ,France ,Boston ,Massachusetts ,Paris ,France General ,French ,Romain Attard ,Christophe Bancel ,Jeanene Timberlake ,Jeffreym Karp Brigham ,Mission French Tech ,Linkedin ,French Tech ,Des Entreprises ,Des Finances ,French Tech Communities ,French Tech Next ,Professor Robert Langer ,Professor Jeffrey ,Ihr Portfolio ,